EU member states have issued updated guidance that should make it easier for sponsors to transition certain multinational trials being conducted under the erstwhile Clinical Trials Directive (CTD) to the Clinical Trials Regulation (CTR) by requiring fewer changes to support the switch.
EU Group Facilitates Switching Multinational Trials To CTR
Second Survey Launched To Identify Remaining Hurdles To CTR Implementation
Revisions to the updated EU guideline on transitioning multinational trials to the Clinical Trials Regulation are said to be “solution oriented.”
More from Europe
More from Geography
• By
The preliminary White House 2026 budget plan cuts agency funding, but not so sharply that user fees are excluded from collection.
• By
An investigation by the US Secretary of Commerce into pharmaceutical imports gives industry an opportunity to comment. AAM CEO John Murphy talked to Pink Sheet's sister publication Scrip about the latest developments.
• By
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include four new products, one of which is Tivdak, Pfizer/Genmab’s treatment for previously treated recurrent or metastatic cervical cancer.